June 19, 2020 / 9:38 PM / a month ago

BRIEF-Vir Biotechnology - On June 15, Co & Wuxi Biologics Entered Into A Binding Letter Of Intent

June 19 (Reuters) - Vir Biotechnology Inc:

* VIR BIOTECHNOLOGY - ON JUNE 15, CO & WUXI BIOLOGICS ENTERED INTO A BINDING LETTER OF INTENT

* VIR BIOTECHNOLOGY - WUXI WILL PERFORM CERTAIN DEVELOPMENT & MANUFACTURING SERVICES FOR CO’S SARS-COV-2 ANTIBODY PROGRAM, IN DEAL

* VIR BIOTECHNOLOGY - CO TO PURCHASE FIRM & BINDING CAPACITY RESERVATION FOR MANUFACTURE OF SPECIFIED NUMBER OF BATCHES OF DRUG SUBSTANCE

* VIR BIOTECHNOLOGY - CO HAS RIGHT TO ORDER AN ADDITIONAL SPECIFIED NUMBER OF BATCHES OF DRUG SUBSTANCE, IN DEAL Source text: bit.ly/2YdV7J4 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below